A U.S. vaccine maker ruined 15 million doses. Its CEO sold US$11 million of stock before that was public

Emergent BioSolutions' stock lost more than half of its value since the disclosure that it ruined as many as 15 million doses of Johnson & Johnson's COVID-19 vaccine at its Baltimore plant. But the company's CEO dumped more than US$11 million worth of stock ahead of the stock's massive decline.